In addition, in multiple preclinical tumor models as well as clinical specimens, activation of CD8 T cells in answer to PD-1 blockade triggers a PD-L1/NLRP3 inflammatory signaling cascade that eventually causes PMN-MDSCs recruitment into melanoma tissue, resulting in immune suppression and thus immune escape [100]. Here, CD8A is linked to neoplasm.